Showing 321 - 340 results of 629 for search '"Hepatocellular carcinoma"', query time: 0.07s Refine Results
  1. 321

    Elevated Preoperative Neutrophil-Lymphocyte Ratio Is Associated with Poor Prognosis in Hepatocellular Carcinoma Patients Treated with Liver Transplantation: A Meta-Analysis by Xiao-Dong Sun, Xiao-Ju Shi, Yu-Guo Chen, Chuan-Lei Wang, Qiang Ma, Guo-Yue Lv

    Published 2016-01-01
    “…This study aims to investigate the prognostic value of neutrophil to lymphocyte ratio (NLR) in hepatocellular carcinoma (HCC) patients treated with liver transplantation (LT) through meta-analysis. …”
    Get full text
    Article
  2. 322
  3. 323
  4. 324
  5. 325
  6. 326

    Sorafenib-Associated Heart Failure Complicated by Cardiogenic Shock after Treatment of Advanced Stage Hepatocellular Carcinoma: A Clinical Case Discussion by Candace Wu, Kamal Shemisa

    Published 2017-01-01
    “…A 76-year-old man with a past medical history of systolic heart failure due to ischemic cardiomyopathy and stage IIIC hepatocellular carcinoma (HCC) presented with symptoms of decompensated heart failure. …”
    Get full text
    Article
  7. 327
  8. 328

    HbA1c-Based Score Model for Predicting Death Risk in Patients with Hepatocellular Carcinoma and Type 2 Diabetes Mellitus by Lingling He, Shuan Zhang, Xiaoli Liu, Yuyong Jiang, Xianbo Wang, Zhiyun Yang

    Published 2017-01-01
    “…To establish a new score model to predict risk of death in patients with hepatocellular carcinoma and type 2 diabetes mellitus. Methods. …”
    Get full text
    Article
  9. 329
  10. 330
  11. 331

    MRI-based deep learning radiomics to differentiate dual-phenotype hepatocellular carcinoma from HCC and intrahepatic cholangiocarcinoma: a multicenter study by Qian Wu, Tao Zhang, Fan Xu, Lixiu Cao, Wenhao Gu, Wenjing Zhu, Yanfen Fan, Ximing Wang, Chunhong Hu, Yixing Yu

    Published 2025-01-01
    “…Abstract Objectives To develop and validate radiomics and deep learning models based on contrast-enhanced MRI (CE-MRI) for differentiating dual-phenotype hepatocellular carcinoma (DPHCC) from HCC and intrahepatic cholangiocarcinoma (ICC). …”
    Get full text
    Article
  12. 332
  13. 333

    Survival and Its Predictors Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma in Ethiopia: A 6-Year Follow-Up Study by Abigia Ashenafi, Soliyana Demelash, Efrata Melaku, Haymanot Abe, Meron Yitna, Fisseha Tekle, Jiksa Dabessa, Biniam Araya, Yared Nigussie, Wondmagegn Demsiss, Ashenafi Zelalem, Song Jung Kim, Nebiyu Dereje

    Published 2025-01-01
    “…PURPOSETo analyze survival and its predictors among patients with hepatocellular carcinoma (HCC) receiving transarterial chemoembolization (TACE) in Ethiopia.MATERIALS AND METHODSWe conducted a retrospective cohort study among patients who received TACE for HCC at MCM Hospital from December 1, 2016, to December 31, 2022. …”
    Get full text
    Article
  14. 334
  15. 335
  16. 336
  17. 337
  18. 338
  19. 339
  20. 340